参考文献/References:
[1]. Hollowell JG,Staehling NW,Flanders WD,et al. Serum TSH,T(4),and thyroid antibodies in the United States population(1988 to 1994):National Health and Nutrition Examination Survey(NHANES Ⅲ)[J].?J Clin Endocrinol Metab,2002,87(2):489-499.
[2]. 中华医学会. 甲状腺功能减退症基层诊疗指南(2019年)[J]. 中华全科医师杂志,2019,18(11):1022-1028.
[3]. 中华医学会. 甲状腺功能亢进症基层诊疗指南(2019年)[J]. 中华全科医师杂志,2019,18(12):1118-1128.
[4]. Mcinnes IB,Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis[J]. Lancet,2017,389(10086):2328-2337.
[5]. Udani K,Patel D,Hart L,et al. Impact of hyperthyroidism on in-hospital outcomes of patients with heart failure[J]. J Community Hosp Intern Med Perspect,2021,11(1):158-162.
[6]. McCoy SS,Crowson CS,Gabriel SE,et al. Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis[J]. J Rheumatol,2012,39(5):954-958.
[7]. Wang Q,Shangguan J,Zhang Y,et al. The prevalence of thyroid autoantibodies in autoimmune connective tissue diseases:a systematic review and meta-analysis[J]. Expert Rev Clin Immunol,2020,16(9):923-930.
[8]. Weetman AP. Diseases associated with thyroid autoimmunity:explanations for the expanding spectrum[J].?Clin Endocrinol(Oxf),2011,74(4):411-418.
[9]. Qamar T,Mukherjee S. Genetic approaches for the diagnosis and treatment of rheumatoid arthritis through personalized medicine[J]. Gene Reports,2021,23:101173.
[10]. Raterman HG,Nurmohamed MT. Hypothyroidism in rheumatoid arthritis—To screen or not to screen?[J]. J Rheumatol,2012,39(5):885-886.
[11]. Mahagna H,Caplan A,Watad A,et al. Rheumatoid arthritis and thyroid dysfunction:a cross-sectional study and a review of the literature[J]. Best Pract Res Clin Rheumatol,2018,32(5):683-691.
[12]. Anoop J,Geetha F,Jyothi I,et al. Unravelling thyroid dysfunction in rheumatoid arthritis:history matters[J]. Int J Rheum Dis,2018,21(3):688-692.
[13]. Huang CM,Sung FC,Chen HJ,et al. Hypothyroidism risk associated with rheumatoid arthritis:a population-based retrospective cohort study[J]. Medicin e(Baltimore),2022,101(1):e28487.
[14]. Boelaert K,Newby PR,Simmonds MJ,et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease[J]. Am J Med,2010,123(2):183. e1-e9.
[15]. Otón T,Carmona L. The epidemiology of established rheumatoid arthritis[J]. Best Pract Res Clin Rheumatol,2019,33(5):101477.
[16]. Lazúrová I,Jochmanová I,Benhatchi K,et al. Autoimmune thyroid disease and rheumatoid arthritis:relationship and the role of genetics[J]. Immunol Res,2014,60(2-3):193-200.
[17]. Ferrari SM,Fallahi P,Ruffilli I,et al. The association of other autoimmune diseases in patients with Graves’ disease(with or without ophthalmopathy):review of the literature and report of a large series[J]. Autoimmun Rev,2019,18(3):287-292.
[18]. Przygodzka M,Filipowicz-Sosnowska A. Prevalence of thyroid diseases and antithyroid antibodies in women with rheumatoid arthritis[J].?Pol Arch Med Wewn,2009,119(1-2):39-43.
[19]. Jang HW,Shin HW,Cho HJ,et al. Identification of HLA-DRB1 alleles associated with Graves’ disease in Koreans by sequence-based typing[J].?Immunol Invest ,2011,40(2):172-182.
[20]. Conigliaro P,Triggianese P,de Martino E,et al. Challenges in the treatment of rheumatoid arthritis[J]. Autoimmun Rev,2019,18(7):706-713.
[21]. Wiersinga WM. Smoking and thyroid[J].?Clin Endocrinol(Oxf),2013,9(2):145-151.
[22]. Scherer HU,H?upl T,Burmester GR. The etiology of rheumatoid arthritis[J].?J Autoimmun,2020,110:102400.
[23]. Raterman HG,Jamnitski A,Lems WF,et al. Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment:a pilot study[J]. J Rheumatol,2011,38(2):247-251.
[24]. Conigliaro P,D’Antonio A,Pinto S,et al. Autoimmune thyroid disorders and rheumatoid arthritis:a bidirectional interplay[J]. Autoimmunity Rev,2020,19(6):102529.
[25]. Elattar E A,Younes TB,Mobasher SA. Hypothyroidism in patients with rheumatoid arthritis and its relation to disease activity[J]. Egypt Rheumatol Rehabil,2014,41:58-65.
[26]. Mcinnes IB,Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis[J]. Lancet,2017,389(10086):2328-2337.
[27]. Raterman HG,Voskuyl AE,Simsek S,et al. Increased progression of carotid intima media thickness in thyroid peroxidase antibodies-positive rheumatoid arthritis patients[J]. Eur J Endocrinol,2013,169(6):751-757.
[28]. 董坤坤. 左甲状腺素治疗亚临床甲状腺功能减退症伴心血管疾病患者的疗效观察[J]. 中国现代药物应用,2021,15(14):114-117.
[29]. Udovcic M,Pena RH,Patham B,et al. Hypothyroidism and the heart[J].?Methodist Debakey Cardiovasc J,2017,13(2):55-59.
[30]. Chen J,Norling LV,Cooper D. Cardiac dysfunction in rheumatoid arthritis:the role of inflammation[J]. Cells,2021,10(4):881.
[31]. Ferreira MB,Fonseca T,Costa R,et al. Prevalence,risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis:the RA-HF study[J]. Eur J Intern Med,2021,85:41-49.
[32]. Johnson TM,Sayles HR,Baker JF,et al. Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis[J]. Ann Rheum Dis,2021,80(11):1385-1392.
[33]. Hsu CY,Su YJ,Chen JF,et al. Patients with rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs at a higher risk of acute coronary syndrome[J]. J Am Heart Assoc,2021,10(8):e018290.
[34]. Raterman HG,Nielen MM,Peters MJ,et al. Coexistence of hypothyroidism with inflammatory arthritis is associated with cardiovascular disease in women[J]. Ann Rheum Dis,2012,71(7):1216-1218.